Buoyed by the breakthrough technologies and methodologies that have enabled earlier intervention, Alzheimer’s drug developers ...

Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced that the U.S. Food & Drug Administration (FDA) cleared its amblyopia ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

Cytisinicline increased biochemically confirmed abstinence nearly threefold versus placebo when taken for 6 weeks and more than fourfold when taken for 12 weeks. The drug was well tolerated with ...

A bill signed into law by Gov. Mike Braun on Tuesday expands the kinds of opioid reversing medications that can be stocked in ...

The simplified requirements for Camzyos are expected to ease prior contraindications, thereby simplifying treatment and ...

Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the ...

Arquitos Capital Management is the general partner to two private investment funds: Arquitos Capital and Arquitos Epicus.

Zai Lab Limited today announced that China's National Medical Products Administration (NMPA) has accepted the supplemental New Drug Application (sNDA) for repotrectinib for the treatment of adult ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) announced that it will present results from six Kelun-led clinical studies at the 2025 American Society of Clinical Oncology (ASCO) Annual ...

HDFC Bank, ICICI Bank, Infosys, Yes Bank, HDFC Life, BHEL, Coal India and Jio Financial Services are among the stocks to ...